Mid-regional pro-adrenomedullin (MR-proADM): an even better prognostic biomarker than C-reactive protein to predict short-term survival in patients with decompensated cirrhosis at risk of infection?

J Hepatol. 2012 Nov;57(5):1156-8; author reply 1158-9. doi: 10.1016/j.jhep.2012.06.036. Epub 2012 Aug 11.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • C-Reactive Protein / analysis*
  • Female
  • Humans
  • Liver Cirrhosis / mortality*
  • Male

Substances

  • C-Reactive Protein